Financial Information FY 2019
Symrise Group
Sales in € million
5.7 % | 1.0 % | 1.3 % | 8.0 % | |
179.3 | 32.0 | 42.6 | ||
3,154.0 | 3,407.9 | |||
FY 2018 | Organic | Portfolio | FX | FY 2019 |
growth |
Sales by Region in € million
(Organic Growth in %)
410.7 | 1,430.6 | |||
+12.8% | +3.6% |
757.9
+7.4%
808.6
+4.2%
EAME
Northern America
Asia/Pacific Latin America
FY 2019 | Change | |||||||||
in € million | FY 2018 | FY 20191 | normalized 1,2 | in % | ||||||
Gross profit | 1,241.5 | 1,367.1 | 1,367.1 | 10.1 | ||||||
EBITDA | 630.5 | 690.9 | 707.2 | 12.2 | ||||||
EBITDA margin | in % | 20.0 | 20.3 | 20.8 | ||||||
EBIT | 434.0 | 464.2 | 480.5 | 10.7 | ||||||
EBIT margin | in % | 13.8 | 13.6 | 14.1 | ||||||
Depreciation | 92.4 | 123.5 | 123.5 | 33.6 | ||||||
Amortization | 104.1 | 103.2 | 103.2 | -0.9 | ||||||
Financial result | - 44.9 | - 45.8 | - 55.7 | 24.0 | ||||||
Earnings before income taxes | 389.0 | 418.4 | 424.8 | 9.2 | ||||||
Net income3 | 275.3 | 298.3 | 303.5 | 10.2 | ||||||
Earnings per share4 | in € | 2.12 | 2.21 | 2.25 | 6.1 | |||||
R&D expenses | 200.4 | 213.3 | 213.3 | 6.4 | ||||||
Investments5 | 226.1 | 181.6 | 181.6 | - 19.7 | ||||||
Business Free Cashflow | ||||||||||
in % of Sales6 | 9.9 | 14.1 | ||||||||
Other Key Figures | Dec 31, 2018 | Dec 31, 2019 | ||||||||
Total assets | 4,920.4 | 5,957.2 | ||||||||
Equity | 1,944.4 | 2,464.4 | ||||||||
Equity ratio | in % | 39.5% | 41.4% | |||||||
Net debt (incl. Provisions for pensions | ||||||||||
and similar obligations)7 | 1,893.1 | 2,221.5 | ||||||||
Net debt (incl. Provisions for pensions | ||||||||||
and similar obligations)7/ EBITDAN | ratio | 3.0 | 3.1 | |||||||
Net debt7 | 1,379.8 | 1,616.7 | ||||||||
Net debt7/ EBITDAN | ratio | 2.2 | 2.3 | |||||||
Employees (balance sheet day) | FTE8 | 9,647 | 10,264 | |||||||
Flavor | ||||||||||
Sales in € million | ||||||||||
3.8 % | 1.8 % | 5.6 % | ||||||||
44.8 | 21.4 | FY 2019 | Change | |||||||
in € million | FY 2018 | FY 20191 | normalized1,2 | in % | ||||||
1,191.1 | 1,257.3 | EBITDA | 243.9 | 268.5 | 10.1 | |||||
EBITDA margin | in % | 20.5 | 21.4 | |||||||
EBIT | 193.2 | 209.4 | 8.4 | |||||||
EBIT margin | in % | 16.2 | 16.7 | |||||||
FY 2018 | Organic | Portfolio | FX | FY 2019 | ||||||
growth | ||||||||||
Nutrition |
Sales in € million
FY 2019 | Change | ||||||||||||||||||||||||
0.1 % | 14.5 % | in € million | FY 2018 | FY 20191 | normalized1,2 | in % | |||||||||||||||||||
9.3 % | 5.0 % | ||||||||||||||||||||||||
EBITDA | 132.3 | 144.4 | 160.7 | 21.5 | |||||||||||||||||||||
0.9 | |||||||||||||||||||||||||
32.0 | |||||||||||||||||||||||||
59.7 | 731.5 | EBITDA margin | in % | 20.7 | 19.7 | 22.0 | |||||||||||||||||||
638.8 | EBIT | 49.0 | 51.5 | 67.7 | 38.2 | ||||||||||||||||||||
EBIT margin | in % | 7.7 | 7.0 | 9.3 | |||||||||||||||||||||
FY 2018 | Organic | Portfolio | FX | FY 2019 | |||||||||||||||||||||
growth |
Scent & Care
Sales in € million
5.6 % | 1.5% | 7.2% | ||
74.8 | 20.2 | |||
1,324.1 | 1,419.1 | |||
FY 2018 | Organic | Portfolio | FX | FY 2019 |
growth |
FY 2019 | Change | ||||||||
in € million | FY 2018 | FY 20191normalized1,2 | in % | ||||||
EBITDA | 254.4 | 278.0 | 9.3 | ||||||
EBITDA margin | in % | 19.2 | 19.6 | ||||||
EBIT | 191.7 | 203.3 | 6.0 | ||||||
EBIT margin | in % | 14.5 | 14.3 |
1 | 2019 numbers including IFRS 16 effect | 3 attributable to shareholders of Symrise AG | 6 | Adjusted for acquisition and IFRS 16 effects | 8 not including apprentices and trainees; |
2 | Adjusted for transaction and integration costs | 4 undiluted | 7 | 2019 including leasing obligations | FTE = full-time equivalent |
related to business combinations | 5 without new leasing contracts |
Attachments
- Original document
- Permalink
Disclaimer
Symrise AG published this content on 10 March 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 10 March 2020 09:28:02 UTC